Profile
SNSE VRTX REGN VRNA ARGX ALNY
Company Name Sensei Biotherapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $11.12M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Christopher W. Gerry Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SNSE VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SNSE VRTX REGN VRNA ARGX ALNY
Last Close $8.14 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $17.58 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.29 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -53.7 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 2706.9 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SNSE VRTX REGN VRNA ARGX ALNY
1 Month Return -30.43 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -1.57 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 2266.28 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 1631.18 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 1560.89 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1596.19 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SNSE VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1398.81 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SNSE VRTX REGN VRNA ARGX ALNY
Asset Growth -39.01 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 3.5 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 18.66 % 9.09 % -131.37 % 24.59 %
Net Income Growth 11.57 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 9.57 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -110.34 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 93.69 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 14.57 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 22.96 % - -143.33 % -107.98 %
Operating 3 Year CFG 10.05 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -236.06 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 93.47 % -100 % 40.15 % 97.08 %
EPS Growth 1.64 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 1.64 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -34.17 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -71.09 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 165.27 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 101.96 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -38.06 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 22.94 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SNSE VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 4.25 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -87.5 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -80 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -106.48 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 97.91 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM 508.23 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1107.42 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM -271.61 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM -17.58 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -17.74 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -17.76 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 1985.35 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 461.37 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1107.42 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.5 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.5 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.5 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
SNSE VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.03B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.03B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.2 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SNSE VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.04B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.03B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.05B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SNSE VRTX REGN VRNA ARGX ALNY
Net Income $-0.03B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.58
AARD Aardvark Therapeutics, Inc. Common Stock 12.71
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.05
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.565
ABPWW 0.0133
ABSI Absci Corporation 2.62
ABUS Arbutus Biopharma Corporation 4.17
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 123.055
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.03
ETFs With Exposure to SNSE
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 341.49
IBB iShares Biotechnology ETF 0 172.73
BIB ProShares Ultra Nasdaq Biotechnology 0 84.89
VXF Vanguard Extended Market Index Fund 0.0001 218.255
IWC iShares Micro-Cap ETF 0.00242 167.885
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 115.06
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.59
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 29.45
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002437 41.315
VTSAX Vanguard Total Stock Market Index Fund 0 166.35
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 8.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0001 166.39
VITSX Vanguard Total Stock Market Index Fund 0 166.38
DFSU Dimensional US Sustainability Core 1 ETF 0.00053483 44.175
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0001 166.41
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VTS.AX Vanguard US Total Market Shares Index ETF 0 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.0001 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 312.11
Unlock